Cardiac Magnetic Resonance Imaging in Diagnostics and Cardiovascular Risk Assessment.

Area of Science:

• Cardiology
• Medical Imaging

Background:

• Left ventricular mass (LVM) indexation is crucial for diagnosing left ventricular hypertrophy and assessing cardiovascular event risk.
• Late gadolinium enhancement (LGE) evaluation guides clinical decisions in diagnosis, cardiovascular assessment, and interventions.
• Novel CMR techniques like T1/T2 mapping offer insights into myocardial fibrosis, edema, and inflammation.

Purpose of the Study:

• To review the current applications of Cardiac Magnetic Resonance (CMR) in cardiac diagnostics.
• To highlight CMR's role in cardiovascular risk assessment.
• To emphasize the potential for personalized patient management through advanced CMR techniques.

Main Methods:

• Review of current literature on Cardiac Magnetic Resonance (CMR) applications.
• Analysis of CMR's utility in assessing left ventricular mass (LVM) and hypertrophy.
• Evaluation of late gadolinium enhancement (LGE) and novel mapping techniques (T1/T2 mapping, tagging, feature tracking).

Main Results:

• CMR enables detailed cardiac function analysis and myocardial tissue characterization.
• Accurate LVM indexation is vital for diagnosing left ventricular hypertrophy and predicting outcomes.
• LGE, T1/T2 mapping, tagging, and feature tracking improve diagnostic accuracy and risk stratification.

Conclusions:

• CMR is a powerful tool for cardiac diagnostics and risk assessment.
• Advanced CMR techniques facilitate personalized patient management strategies.
• Further integration of CMR in clinical practice can optimize cardiovascular care.